Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

340B Expansion, Revisions Becoming Front-Burner Issues For Pharma

Executive Summary

Moves to expand and revise the federal 340B drug discount program as part of broad health care reform legislation are becoming high-profile concerns in the pharmaceutical industry

You may also be interested in...



Final Health Reform Bill Looks Positive For Pharma Firms

It has been a long haul to get to the final iteration of proposed health care reform legislation released March 18, and it appears that the pharmaceutical industry's patience and lobbying efforts have garnered an overall positive result

Final Health Reform Bill Looks Positive For Pharma Firms

It has been a long haul to get to the final iteration of proposed health care reform legislation released March 18, and it appears that the pharmaceutical industry's patience and lobbying efforts have garnered an overall positive result

340B For All? Rx Discount Expansion Coming -- With Or Without Health Reform

The pharmaceutical industry should prepare for an expansion of the 340B drug discount program in the U.S. - regardless of the outcome of the health care reform debate

Topics

UsernamePublicRestriction

Register

PS051657

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel